February 13, 2017
MHLW Councilor Kazuhiko Mori Few drugs will be subject to the so-called “optimal use promotion guidelines” because they will only cover trailblazer medicines with novel mechanisms of action, Kazuhiko Mori, councilor in charge of pharmaceuticals at the Health Minister’s Secretariat,...read more